- Home
- WNS vs ALVO Comparison
WNS vs ALVO Comparison
Compare WNS & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNS
- ALVO
- Stock Information
- Founded
- WNS 1996
- ALVO 2013
- Country
- WNS India
- ALVO Luxembourg
- Employees
- WNS N/A
- ALVO N/A
- Industry
- WNS Business Services
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- WNS Consumer Discretionary
- ALVO Health Care
- Exchange
- WNS Nasdaq
- ALVO Nasdaq
- Market Cap
- WNS 2.5B
- ALVO 2.5B
- IPO Year
- WNS N/A
- ALVO N/A
- Fundamental
- Price
- WNS $74.88
- ALVO $8.46
- Analyst Decision
- WNS Hold
- ALVO
- Analyst Count
- WNS 9
- ALVO 0
- Target Price
- WNS $67.67
- ALVO N/A
- AVG Volume (30 Days)
- WNS 2.0M
- ALVO 358.1K
- Earning Date
- WNS 07-24-2025
- ALVO 08-13-2025
- Dividend Yield
- WNS N/A
- ALVO N/A
- EPS Growth
- WNS 28.20
- ALVO N/A
- EPS
- WNS 3.60
- ALVO 0.34
- Revenue
- WNS $1,345,642,000.00
- ALVO $587,890,000.00
- Revenue This Year
- WNS $6.16
- ALVO $36.67
- Revenue Next Year
- WNS $9.31
- ALVO $42.58
- P/E Ratio
- WNS $20.81
- ALVO $24.90
- Revenue Growth
- WNS 1.94
- ALVO 413.92
- 52 Week Low
- WNS $42.62
- ALVO $7.35
- 52 Week High
- WNS $75.14
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- WNS 78.71
- ALVO 39.31
- Support Level
- WNS $74.75
- ALVO $8.31
- Resistance Level
- WNS $75.00
- ALVO $9.94
- Average True Range (ATR)
- WNS 0.17
- ALVO 0.34
- MACD
- WNS -0.55
- ALVO -0.06
- Stochastic Oscillator
- WNS 46.94
- ALVO 9.20
About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)
WNS (Holdings) Ltd is a provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically, the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), South Africa, and other countries.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.